Filter
2157
Filtered Results: 2157
Text search:
TB
Treatment
outcomes
Featured
Recommendations
210
New Publications
658
Language
Document type
No document type
1469
Studies & Reports
288
Guidelines
212
Manuals
59
Strategic & Response Plan
58
Fact sheets
24
Training Material
23
Situation Updates
11
Infographics
8
Resource Platforms
4
Videos
1
Countries / Regions
India
94
Kenya
91
South Africa
86
Western and Central Europe
58
Tanzania
55
Global
54
Ethiopia
53
Malawi
53
Uganda
49
Zambia
46
Nepal
43
Namibia
40
Africa
38
Eastern Europe
38
Sierra Leone
37
Myanmar / Burma
35
Liberia
33
Rwanda
32
Lesotho
31
Nigeria
29
Bangladesh
29
Ghana
28
Cambodia
22
Asia
20
Ukraine
19
Latin America and the Carribbean
18
Philippines
17
Zimbabwe
16
Mozambique
15
Botswana
15
South–East Asia Region
15
Russia
13
Senegal
9
Pakistan
9
East and Southern Africa
9
Syria
8
Eswatini/ Swaziland
8
Indonesia
7
Colombia
7
Congo, Democratic Republic of
6
South Sudan
6
Albania
6
Burkina Faso
5
Benin
5
West and Central Africa
5
Middle East and North Africa
5
Georgia
5
Haiti
4
Germany
4
Lebanon
4
Thailand
4
Sudan
4
Argentina
4
Brazil
4
Eastern Europe and Central Asia
4
Southern Africa
4
Tajikistan
4
Guinea
3
USA
3
Jordan
3
Afghanistan
3
Angola
3
Yemen
3
Western Pacific Region
3
Laos
3
Timor Leste/ East Timor
3
Iran
3
Vietnam
3
Saudi Arabia
2
Cameroon
2
Somalia
2
Iraq
2
Peru
2
Sri Lanka
2
Estonia
2
North America
2
Guinea-Bissau
1
Morocco
1
Egypt
1
Gambia
1
Ireland
1
Papua New Guinea
1
Central African Republic
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Madagascar
1
Chile
1
Paraguay
1
Bhutan
1
Venezuela
1
Palestine
1
Djibouti
1
Armenia
1
Qatar
1
Bulgaria
1
Uruguay
1
Turkmenistan
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
945
Clinical Guidelines
182
Public Health
91
Women & Child Health
59
Key Resources
33
Capacity Building
31
Pharmacy & Technologies
17
Toolboxes
TB
449
HIV
339
AMR
72
Mental Health
64
COVID-19
58
Caregiver
46
NCDs
32
Pharmacy
31
NTDs
31
Global Health Education
30
Ebola
26
Disability
19
Conflict
19
Refugee
18
Polio
17
Rapid Response
15
Health Financing Toolbox
15
Planetary Health
14
Natural Hazards
8
Social Ethics
4
Cholera
3
Zika
3
Specific Hazards
2
HIV & AIDS Treatment in Practice No. 198
braz j infect dis 2 0 1 7;2 1(2):162–170
http://dx.doi.org/10.1016/j.bjid.2016.11.006
1413-8670/© 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
20 April 2022. The response to the COVID-19 pandemic continues to adversely affect essential TB services in many countries. A first report of case studies was published in 2021 comprising 23 examples of innovative interventions implemented by countr...
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These pa...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB thro...
Diagnosis and Treatment Outcomes of Tuberculosis in Relation to Gender and HIV Status in South Benin
Journal of Tuberculosis Research, 2017, 5, 189-200
Background: In Benin, little is known about the influence of both gender and
HIV-status on diagnostic patterns and treatment outcomes of Tuberc...
Patients and TB: Improving treatment outcomes through a patient centred approach and access to new treatments
5th ... Symposium – Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs of Georgia and Médecins Sans Frontières
22- 23 March , 2016 , TBILISI , GEORGIA
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and ...
The Roadmap towards ending TB among children and adolescents, third edition builds on the 2013 and 2018 versions. The 2023 version recognizes the progress made over the past five years and outlines priorities and key actions designed to accelerate p...
Systematic screening for TB disease is the systematic identification of people at risk for TB disease, in a predetermined target group, by assessing symptoms and using tests, examinations or other p...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR ....
The term "Programmatic Management of Drug Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The term "Programmatic Management of Drug Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organi...
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. ... success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked medicines for all patients with MDR-TB.
PloS One October 2012 | Volume 7 | Issue 10 | e46943
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescen...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on ... and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support countries in the evidence-informed introduction and scale-up of holistic people-centred services for TB, comorbidities and health-related risk factors, with the goal of comprehensively addressing TB and other co-existing health conditions. It should be used in conjunction with relevant WHO guidelines. The Framework is intended for use by people working in ministries of health, other relevant line-ministries, policymakers, international technical and funding organizations, researchers, nongovernmental and civil society organizations, as well as primary care workers, specialist health practitioners, and community health workers who support the response to TB and comorbidities in both the public and private sectors.
